مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.

Authors : Krugliak Cleveland N; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA. .; Ghosh S

Subjects: Adalimumab*/Adalimumab*/Adalimumab*/therapeutic use ; Adalimumab*/Adalimumab*/Adalimumab*/adverse effects ; Infliximab*/Infliximab*/Infliximab*/therapeutic use

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 17; Vol. 24 (1), pp. 314. Date of Electronic Publication: 2024 Sep 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Sex differences in Helicobacter pylori infection and recurrence rate among 81,754 Chinese adults: a cross-sectional study.

Authors : Qiao Y; The First School of Clinical Medicine of Lanzhou University, Lanzhou, 730000, China.; Zhou Y

Subjects: Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/epidemiology ; Helicobacter pylori*

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 11; Vol. 24 (1), pp. 305. Date of Electronic Publication: 2024 Sep 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.

Authors : Wei S; Department of Infectious Diseases, Shunde Hospital, Southern Medical University, Foshan, 528308, China.; Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzhou, 510080, China.

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy; Humans ; Alanine Transaminase

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Mar 27; Vol. 24 (1), pp. 120. Date of Electronic Publication: 2024 Mar 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.

Authors : Zhou Y; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road , 510630, Guangzhou City, Guangdong Province, China.; Liang M

Subjects: Benzimidazoles* ; Benzopyrans* ; Carbamates*

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Feb 14; Vol. 24 (1), pp. 73. Date of Electronic Publication: 2024 Feb 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial.

Authors : Oh CK; Department of Internal Medicine, Gangnam Sacred Heart Hospital, Hallym University College of Medicine, 1 Singil-ro, Yeoungdeungpo-gu, Seoul, 07441, Korea.; Institute for Liver and Digestive Diseases, Hallym University, 1 Hallymdaehak-gil, Chuncheon, 24252, Korea.

Subjects: Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy ; Helicobacter pylori*; Humans

Source: BMC gastroenterology [BMC Gastroenterol] 2023 Dec 21; Vol. 23 (1), pp. 453. Date of Electronic Publication: 2023 Dec 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma.

Authors : Hokamura N; Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo, 173-8606, Japan. .; Fukagawa T

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage ; Cisplatin*/Cisplatin*/Cisplatin*/adverse effects ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 02; Vol. 24 (1), pp. 295. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study.

Authors : Rezazadeh M; Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Agah S

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 28; Vol. 24 (1), pp. 382. Date of Electronic Publication: 2024 Oct 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.

Authors : Zhou P; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, 430022, China.; Sun X

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/mortality

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 19; Vol. 24 (1), pp. 371. Date of Electronic Publication: 2024 Oct 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon.

Authors : Sharara AI; Division of Gastroenterology, American University of Beirut Medical Center, P.O. Box 11-0236/16-B, Beirut, Lebanon. .; Alrazim A

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Pyrimidines*/Pyrimidines*/Pyrimidines*/therapeutic use ; Pyrimidines*/Pyrimidines*/Pyrimidines*/adverse effects

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 04; Vol. 24 (1), pp. 349. Date of Electronic Publication: 2024 Oct 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The impact of the COVID-19 surge after the end of China's Zero-COVID policy on the health-related quality of life of IBD patients.

Authors : Wang R; Department of General Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.; Liu P

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/psychology ; Quality of Life*

Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 16; Vol. 24 (1), pp. 312. Date of Electronic Publication: 2024 Sep 16.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.

Sex differences in Helicobacter pylori infection and recurrence rate among 81,754 Chinese adults: a cross-sectional study.

Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.

Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.

Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial.

Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma.

Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study.

Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.

Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon.

The impact of the COVID-19 surge after the end of China's Zero-COVID policy on the health-related quality of life of IBD patients.

اتصل بنا

اتبع